NOVO.B.DK

256.75

+3.84%↑

GMAB.DK

1,717

-1.97%↓

HLUNB.DK

44.08

+1.8%↑

ZEAL.DK

302.7

-1.08%↓

AMBUB.DK

65.35

-2.1%↓

NOVO.B.DK

256.75

+3.84%↑

GMAB.DK

1,717

-1.97%↓

HLUNB.DK

44.08

+1.8%↑

ZEAL.DK

302.7

-1.08%↓

AMBUB.DK

65.35

-2.1%↓

NOVO.B.DK

256.75

+3.84%↑

GMAB.DK

1,717

-1.97%↓

HLUNB.DK

44.08

+1.8%↑

ZEAL.DK

302.7

-1.08%↓

AMBUB.DK

65.35

-2.1%↓

NOVO.B.DK

256.75

+3.84%↑

GMAB.DK

1,717

-1.97%↓

HLUNB.DK

44.08

+1.8%↑

ZEAL.DK

302.7

-1.08%↓

AMBUB.DK

65.35

-2.1%↓

NOVO.B.DK

256.75

+3.84%↑

GMAB.DK

1,717

-1.97%↓

HLUNB.DK

44.08

+1.8%↑

ZEAL.DK

302.7

-1.08%↓

AMBUB.DK

65.35

-2.1%↓

Search

Coloplast A-S (Class B)

Abrir

413.2 -1.24

Visão Geral

Variação de preço das ações

24h

Atual

Mín

407.2

Máximo

419.4

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.492

60.328

EPS

6.32

Rendimento de Dividendos

5.28

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.28%

2.24%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-21B

98B

Abertura anterior

414.44

Fecho anterior

413.2

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 de abr. de 2026, 23:47 UTC

Conversa de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 de abr. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 de abr. de 2026, 22:33 UTC

Ganhos

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Executed Offtake Agreement With Ronbay

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 de abr. de 2026, 22:16 UTC

Ganhos

PLS Commences Commissioning of Midstream Demonstration Plant

23 de abr. de 2026, 22:15 UTC

Ganhos

PLS Group Reaffirms FY26 Guidance for All Metrics

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 de abr. de 2026, 22:13 UTC

Ganhos

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:11 UTC

Ganhos

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 de abr. de 2026, 22:10 UTC

Ganhos

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 de abr. de 2026, 22:09 UTC

Ganhos

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 de abr. de 2026, 22:08 UTC

Ganhos

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 de abr. de 2026, 22:04 UTC

Ganhos

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 de abr. de 2026, 21:56 UTC

Conversa de Mercado
Ganhos

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 de abr. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 de abr. de 2026, 21:27 UTC

Ganhos

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 de abr. de 2026, 21:25 UTC

Ganhos

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 de abr. de 2026, 21:24 UTC

Ganhos

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 de abr. de 2026, 21:24 UTC

Ganhos

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat